Bristol Myers Squibb Co. (BMY)
67.31
+0.30
(+0.45%)
USD |
NYSE |
Aug 24, 16:00
67.13
-0.18
(-0.27%)
After-Hours: 20:00
Bristol Myers Squibb Total Assets (Quarterly) : 87.63B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 87.63B |
| March 31, 2026 | 86.48B |
| December 31, 2025 | 90.04B |
| September 30, 2025 | 96.89B |
| June 30, 2025 | 94.68B |
| March 31, 2025 | 92.43B |
| December 31, 2024 | 92.60B |
| September 30, 2024 | 93.67B |
| June 30, 2024 | 94.65B |
| March 31, 2024 | 99.03B |
| December 31, 2023 | 95.16B |
| September 30, 2023 | 91.26B |
| June 30, 2023 | 93.49B |
| March 31, 2023 | 94.28B |
| December 31, 2022 | 96.82B |
| September 30, 2022 | 98.20B |
| June 30, 2022 | 100.36B |
| March 31, 2022 | 103.03B |
| December 31, 2021 | 109.31B |
| September 30, 2021 | 110.89B |
| June 30, 2021 | 110.80B |
| March 31, 2021 | 112.44B |
| December 31, 2020 | 118.48B |
| September 30, 2020 | 125.54B |
| June 30, 2020 | 128.08B |
| Date | Value |
|---|---|
| March 31, 2020 | 129.28B |
| December 31, 2019 | 129.94B |
| September 30, 2019 | 57.43B |
| June 30, 2019 | 55.16B |
| March 31, 2019 | 34.83B |
| December 31, 2018 | 34.99B |
| September 30, 2018 | 33.73B |
| June 30, 2018 | 32.64B |
| March 31, 2018 | 33.08B |
| December 31, 2017 | 33.55B |
| September 30, 2017 | 33.98B |
| June 30, 2017 | 33.41B |
| March 31, 2017 | 32.94B |
| December 31, 2016 | 33.71B |
| September 30, 2016 | 33.73B |
| June 30, 2016 | 32.83B |
| March 31, 2016 | 31.89B |
| December 31, 2015 | 31.75B |
| September 30, 2015 | 31.78B |
| June 30, 2015 | 31.95B |
| March 31, 2015 | 33.58B |
| December 31, 2014 | 33.75B |
| September 30, 2014 | 33.45B |
| June 30, 2014 | 33.50B |
| March 31, 2014 | 33.42B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
| Merck & Co., Inc. | 129.80B |
| Pfizer Inc. | 201.13B |
| AstraZeneca PLC | 114.02B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 65.32B |
| Shareholders Equity (Quarterly) | 22.32B |
| Debt to Equity Ratio | 2.019 |
| Current Ratio | 1.532 |
| Net Debt Paydown Yield | 1.05% |